BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15129818)

  • 1. Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.
    Aversa A; Pili M; Fabbri A; Spera E; Spera G
    J Endocrinol Invest; 2004 Feb; 27(2):192-206. PubMed ID: 15129818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
    Francis SH; Corbin JD
    Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
    Küthe A; Montorsi F; Andersson KE; Stief CG
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1489-95. PubMed ID: 12431025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Carson CC; Lue TF
    BJU Int; 2005 Aug; 96(3):257-80. PubMed ID: 16042713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats.
    Wilkes N; White S; Stein P; Bernie J; Rajasekaran M
    Int J Impot Res; 2004 Apr; 16(2):187-94. PubMed ID: 15073608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide regulation of penile erection: biology and therapeutic implications.
    Burnett AL
    J Androl; 2002; 23(5):S20-6. PubMed ID: 12236169
    [No Abstract]   [Full Text] [Related]  

  • 9. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile mechanisms in diabetes-related erectile dysfunction.
    Disanto ME
    Curr Pharm Des; 2005; 11(31):3995-4010. PubMed ID: 16378506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile dysfunction.
    Shabsigh R; Anastasiadis AG
    Annu Rev Med; 2003; 54():153-68. PubMed ID: 12525671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors.
    Sommer F; Schulze W
    World J Urol; 2005 Dec; 23(6):385-92. PubMed ID: 16273418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase 5 mechanisms and therapeutic applications.
    Burnett AL
    Am J Cardiol; 2005 Dec; 96(12B):29M-31M. PubMed ID: 16387563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Lau DH; Thompson CS; Morgan RJ; Mumtaz FH; Mikhailidis DP
    BJU Int; 2005 Dec; 96(9):1424. PubMed ID: 16287475
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
    World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction.
    Andersson KE
    Pharmacol Rev; 2011 Dec; 63(4):811-59. PubMed ID: 21880989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction.
    Corbin JD; Francis SH
    J Androl; 2003; 24(6 Suppl):S38-41. PubMed ID: 14581493
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey.
    Kim NN
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology of erectile function.
    Sáenz de Tejada I; Angulo J; Cellek S; González-Cadavid N; Heaton J; Pickard R; Simonsen U
    J Sex Med; 2004 Nov; 1(3):254-65. PubMed ID: 16422955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.